Clinical Characteristics and Outcomes Among Travelers With Severe Dengue : A GeoSentinel Analysis.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
07 2023
Historique:
medline: 19 7 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

Dengue virus is a flavivirus transmitted by To describe the epidemiology, clinical characteristics, and outcomes among international travelers with severe dengue or dengue with warning signs as defined by the 2009 World Health Organization classification (that is, complicated dengue). Retrospective chart review and analysis of travelers with complicated dengue reported to GeoSentinel from January 2007 through July 2022. 20 of 71 international GeoSentinel sites. Returning travelers with complicated dengue. Routinely collected surveillance data plus chart review with abstraction of clinical information using predefined grading criteria to characterize the manifestations of complicated dengue. Of 5958 patients with dengue, 95 (2%) had complicated dengue. Eighty-six (91%) patients had a supplemental questionnaire completed. Eighty-five of 86 (99%) patients had warning signs, and 27 (31%) were classified as severe. Median age was 34 years (range, 8 to 91 years); 48 (56%) were female. Patients acquired dengue most frequently in the Caribbean ( Data for some variables could not be retrieved by chart review for some patients. The generalizability of our observations may be limited. Complicated dengue is relatively rare in travelers. Clinicians should monitor patients with dengue closely for warning signs that may indicate progression to severe disease. Risk factors for developing complications of dengue in travelers need further prospective study. Centers for Disease Control and Prevention, International Society of Travel Medicine, Public Health Agency of Canada, and GeoSentinel Foundation.

Sections du résumé

BACKGROUND
Dengue virus is a flavivirus transmitted by
OBJECTIVE
To describe the epidemiology, clinical characteristics, and outcomes among international travelers with severe dengue or dengue with warning signs as defined by the 2009 World Health Organization classification (that is, complicated dengue).
DESIGN
Retrospective chart review and analysis of travelers with complicated dengue reported to GeoSentinel from January 2007 through July 2022.
SETTING
20 of 71 international GeoSentinel sites.
PATIENTS
Returning travelers with complicated dengue.
MEASUREMENTS
Routinely collected surveillance data plus chart review with abstraction of clinical information using predefined grading criteria to characterize the manifestations of complicated dengue.
RESULTS
Of 5958 patients with dengue, 95 (2%) had complicated dengue. Eighty-six (91%) patients had a supplemental questionnaire completed. Eighty-five of 86 (99%) patients had warning signs, and 27 (31%) were classified as severe. Median age was 34 years (range, 8 to 91 years); 48 (56%) were female. Patients acquired dengue most frequently in the Caribbean (
LIMITATIONS
Data for some variables could not be retrieved by chart review for some patients. The generalizability of our observations may be limited.
CONCLUSION
Complicated dengue is relatively rare in travelers. Clinicians should monitor patients with dengue closely for warning signs that may indicate progression to severe disease. Risk factors for developing complications of dengue in travelers need further prospective study.
PRIMARY FUNDING SOURCE
Centers for Disease Control and Prevention, International Society of Travel Medicine, Public Health Agency of Canada, and GeoSentinel Foundation.

Identifiants

pubmed: 37335991
doi: 10.7326/M23-0721
doi:

Substances chimiques

Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-948

Subventions

Organisme : NCEZID CDC HHS
ID : U50 CK000189
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Auteurs

Ralph Huits (R)

Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy (R.H.).

Kristina M Angelo (KM)

Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (K.M.A.).

Bhawana Amatya (B)

CIWEC Hospital and Travel Medicine Center, Kathmandu, Nepal (B.A.).

Sapha Barkati (S)

J.D. MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada (S.B.).

Elizabeth D Barnett (ED)

Section of Pediatric Infectious Diseases, Boston Medical Center, Boston, Massachusetts (E.D.B., M.L.).

Emmanuel Bottieau (E)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium (E.B.).

Hannah Emetulu (H)

International Society of Travel Medicine, Atlanta, Georgia (H.E., A.R.).

Loïc Epelboin (L)

Infectious and Tropical Diseases Unit and CIC Inserm 1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana (L.E.).

Gilles Eperon (G)

Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland (G.E.).

Line Medebb (L)

Aix Marseille University, AP-HM, IHU-Méditerranée Infection, Marseille, France (L.M.).

Federico Gobbi (F)

Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona, and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy (F.G.).

Martin P Grobusch (MP)

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands (M.P.G.).

Oula Itani (O)

Institut Pasteur, Centre Médical, Centre d'Infectiologie Necker-Pasteur, Paris, France (O.I.).

Sabine Jordan (S)

Division of Tropical Medicine, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, and Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (S.J.).

Paul Kelly (P)

BronxCare Hospital Center, Bronx, New York (P.K.).

Karin Leder (K)

School of Public Health and Preventive Medicine, Monash University, and Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Victoria, Australia (K.L.).

Marta Díaz-Menéndez (M)

Tropical Medicine Department, Hospital Universitario La Paz-Carlos III, IdIPAz, and CIBERINFECT, Madrid, Spain (M.D.).

Nobumasa Okumura (N)

Center Hospital of the National Center for Global Health and Medicine, Shinjuku City, Tokyo, Japan (N.O.).

Aisha Rizwan (A)

International Society of Travel Medicine, Atlanta, Georgia (H.E., A.R.).

Camilla Rothe (C)

Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-Universität München, Munich, Germany (C.R.).

Mauro Saio (M)

Doctor's Plaza, Nairobi Hospital, Nairobi, Kenya (M.S.).

Jesse Waggoner (J)

Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia (J.W.).

Yukihiro Yoshimura (Y)

Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan (Y.Y.).

Michael Libman (M)

Section of Pediatric Infectious Diseases, Boston Medical Center, Boston, Massachusetts (E.D.B., M.L.).

Davidson H Hamer (DH)

Department of Global Health, Boston University School of Public Health, Section of Infectious Diseases, Boston University School of Medicine, Center for Emerging Infectious Disease Policy and Research, Boston University, and National Emerging Infectious Disease Laboratory, Boston, Massachusetts (D.H.H.).

Eli Schwartz (E)

The Center of Geographical Medicine and Tropical Diseases, Sheba Medical Center, Tel HaShomer, and Ramat Gan & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (E.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH